| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―03 |
Mutations Unveiled: Navigating the Ever-Changing Landscape of SARSCoV-2 in the COVID-19 Saga |
Niraj Patil, Amandeep Singh |
| 2 |
[GO] |
2024―Apr―13 |
Screening of Some Ayurvedic Phytochemicals to Identify Potential Inhibitors against SARS-CoV-2 Mpro by In Silico Computational Approach |
V. Alagarsamy, P. Shyam Sundar, B. Narendhar, M. T. Sulthana, V. Raja Solomon, A. Dharshini Aishwarya, V. Ravikumar, M. Rupeshkumar, K. Kavitha, M. Gobinath, S. Nivedhitha, P. Parthiban |
| 3 |
[GO] |
2024―Mar―11 |
Evidence of Neutralizing Antibodies Indicating the Cure of PatientsInfected
with COVID-19 Within one Month of Infection |
Yasir M. Abdulateef, Zainab N. Ayad, Haitham Noaman, Marwa F. Fadhel, Mahammad Z. Taha, Fatima M. Rafeeq, Ahmed Y. Salih |
| 4 |
[GO] |
2024―Feb―14 |
Pyolytics: A Step Forward to Address Respiratory Hypoxia in Coronavirus
Infection |
Ilnur Yagudin, Darya Suntsova |
| 5 |
[GO] |
2024―Feb―02 |
Hierarchical Virtual Screening of SARS-CoV-2 Main Protease Potential Inhibitors: Similarity Search, Pharmacophore Modeling, and Molecular
Docking Study |
Huda Mando, Iyad allous |
| 6 |
[GO] |
2023―Jul―18 |
Novel and Predictive QSAR Model and Molecular Docking: New Natural Sulfonamides of Potential Concern Against SARS-Cov-2 |
Nathalie Moussa, Hoda Mando |
| 7 |
[GO] |
2023―Jul―17 |
Safety and efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 patients: a systematic review of current evidence |
Esmaeil Mehraeen, Ehsan Ghavimehr, Ali Zand, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Hamid Zaferani Arani, Pegah Mirzapour, Zahra Pashaei, Omid Dadras |
| 8 |
[GO] |
2023―May―03 |
Role of Molnupiravir in the Treatment of COVID-19 |
Vaishali M. Patil, Aman Sharma, Meenakshi Dahiya, Gaurav Pratap Singh, Anirudh Malik |
| 9 |
[GO] |
2022―Sep―27 |
Therapeutic uses of antihistamines in the management of COVID-19: a narrative review |
Hesamoddin Hosseinjani, Mahshid Ataei, Omid Arasteh, Armin Salek Maghsoudi, Shokoufeh Hassani |
| 10 |
[GO] |
2022―Sep―23 |
Successful combination of remdesivir and convalescent plasma to treat a patient with rituximab-related B-cell deficiency and prolonged COVID-19: A case report |
Giorgio Raho, William Cordeddu, Davide Firinu, Stefano Del Giacco, Goffredo Angioni |
| 11 |
[GO] |
2022―Aug―02 |
Therapeutic Potentials of Black Seeds (Nigella sativa) in the Management of COVID-19 -A Review of Clinical and In-silico Studies |
Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Sudha Muthusamy, Mirunalini Gobinath, Mohamed Rafiullah |
| 12 |
[GO] |
2022―Jul―31 |
Is It Possible to Control the Outbreak of COVID-19 in Dharavi, Asia’s Largest Slum Situated in Mumbai? |
Ranjan K. Mohapatra |
| 13 |
[GO] |
2022―Jul―31 |
The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis |
Timotius Ivan Hariyanto |
| 14 |
[GO] |
2022―May―19 |
Comparison of efficacy of remdesivir with supportive care alone in the treatment of critically sick adult and child COVID-19 patients: A randomized clinical trial |
Ahmad Hormati, Sajjad Ahmadpour, Mohammad Reza Ghadir, Seyed Yaser Foroghi Ghomi, Javad Tafaroji, Zahra Movahedi, Seyed Kamal Eshagh Hossaini, Morteza Khoshgoftar, Mina Gheitani |
| 15 |
[GO] |
2022―May―16 |
Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; The HOPE- Covid-19 Registry. |
Iván J. Núñez-Gil, Luis Ayerbe, Cristina Fernandez-Pérez, Vicente Estrada, Charbel Maroun Eid, Ramón Arroyo-Espliguero, Rodolfo Romero, Víctor Manuel Becerra-Muñoz, Aitor Uribarri, Gisela Feltes, Daniela Trabattoni, María Molina, Marcos García Aguado, Martino Pepe, Enrico Cerrato, Jia Huang, Thamar Capel Astrua, Emilio Alfonso, Alex F. Castro-Mejía, Sergio Raposeiras-Roubin, Luis Buzón, Carolina Espejo Paeres, Alba Mulet, Nisha Lal-Trehan, Elisa Garcia-Vazquez, Oscar Fabregat-Andres, Ibrahim Akin, Fabrizio D´Ascenzo, Paula Gomez-Rosado, Fabrizio Ugo, Antonio Fernández-Ortiz, Carlos Macaya |
| 16 |
[GO] |
2022―May―11 |
Recent evidence-based treatments for COVID-19: A Review |
Faraat Ali, Varisha Anjum, Garima Chauhan, Asad Ali, Javed Ahamad |
| 17 |
[GO] |
2022―Apr―30 |
Post COVID-19: Risk-factors, prevention and management of black fungus |
Aimen Salman, Suneela Dhaneshwar, Shaik Shafiulla |
| 18 |
[GO] |
2022―Apr―26 |
Antiviral Potential of Medicinal Plants for the COVID-19 |
Yashika Sharma, Sulochana Kaushik, Sanjit Boora, Pawan Kumar, Ajit Kumar, Jaya Parkash Yadav, Samander Kaushik |
| 19 |
[GO] |
2022―Apr―06 |
Second Wave of Covid-19 with Seasonal Influenza (Flu) in Uttar Pradesh, Northern India: A Cohort Study |
Nadeem Rais, Akash Ved, Rizwan Ahmad, Kehkashan Parveen, Om Prakash, Darakhshan Gazala Bari, Khursheed Ahmad, Muhammad Farman, Naze Alam |
| 20 |
[GO] |
2022―Mar―30 |
‘Black Fungus’- An alarming infection during novel coronavirus- A Review |
Raneet Das, Jayita Roy, Sumel Ashique |
| 21 |
[GO] |
2021―Dec―24 |
Use of the genus Satureja as food supplement: possible modulation of the immune system via intestinal microbiota during SARS-CoV-2 infection? |
Abdelkarim Ezaouine, Badreddine Nouadi, Yousra Sbaoui, Mariam El Messal, Fatima Chegdani, Faïza Bennis |
| 22 |
[GO] |
2021―Dec―03 |
In silico drug repurposing for the identification of antimalarial drugs as candidate inhibitors of SARS-CoV-2 |
Praveen Kumar Pasla, Pugazhenthan Thangaraju, Sree Sudha TY, Sri Chandana M, Rizwaan Abbas S |
| 23 |
[GO] |
2021―Dec―01 |
'Mucormycosis' A Fungal Infection Threatening India During COVID-19' - A Review |
Sumel Ashique |
| 24 |
[GO] |
2021―Oct―04 |
Anti-HIV Integrase Inhibitors as New Candidates for the Treatment of COVID-19: A Narrative Literature Review |
Sofia Salari, Hedyieh Karbasforooshan, Hesamoddin Hosseinjani |
| 25 |
[GO] |
2021―Jul―20 |
Screening of phytochemicals from Curcuma longa for their inhibitory activity on SARS-CoV-2: An in-silico study |
Preeya Negi, Lalita Das, Surya Prakash, Vaishali M. Patil |
| 26 |
[GO] |
2021―May―09 |
Essentials in the Treatment of Covid-19 |
Fatemeh Mehrabi Rad, Hossein Elyasi, Hadis Rahimi, Amir Zamani, Amirhossein Nafari |
| 27 |
[GO] |
2021―Feb―18 |
A recent update on the clinical trials and effectiveness of drugs used in COVID-19, MERS and SARS Coronaviruses. |
Seyed Sajad Hosseini Balef, Zohreh Karimi, Ala Azari, Seyed Sadeq Sadraie, Parisa Hasanjani, Yasaman Sadeghi, Samin Ahmadi, Fatemeh Qorbannejad, Ali Farmoudeh, Hamid Irannejad |
| 28 |
[GO] |
2021―Jan―19 |
Understanding the Dynamics of COVID-19 Outbreak: Structure, Diagnosis, Prevention and Treatment |
Rohan R. Narkhede, Rameshwar S. Cheke, Sachin D. Shinde, Vitthal G. Kuchake, Nilesh M. Mahajan, Vaishali M. Patil |
| 29 |
[GO] |
2020―Nov―19 |
Postpartum Posterior Reversible Encephalopathy Syndrome in A Patient Suspected to COVID-19 |
Fatemeh Ramezanpour, Ashraf Zarvani, Athena Sharifi-Razavi |
| 30 |
[GO] |
2020―Oct―21 |
Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status |
Rina Das, Dinesh Kumar Mehta, Meenakshi Dhanawat |
| 31 |
[GO] |
2020―Oct―11 |
The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis |
Timotius Ivan Hariyanto, Felix Kwenandar, Karunia Valeriani Japar, Vika Damay, Andree Kurniawan |
| 32 |
[GO] |
2020―Oct―07 |
Covid-19: Outbreak to Global |
Deepika Paliwal, Shoaib Khan, Anindita Chaki |
| 33 |
[GO] |
2020―Oct―07 |
Does metformin satisfy as an option for host directed therapy in COVID-19? |
Pugazhenthan Thangaraju, Atul Jindal, Sajitha Venkatesan, Meenalotchini Prakash Gurunthalingam, Nanditha Venkatesan, Eswaran Thangaraju |
| 34 |
[GO] |
2020―Sep―28 |
Coronavirus Disease-19 (COVID-19): Systematic analysis of situation in Pakistan-Responses and potential advancements |
Muhammad Imran Din, Jawayria Najeeb, Maryam Zaheer Kiyani, Rida Khalid |
| 35 |
[GO] |
2020―Sep―28 |
Drug Repositioning: A Smart Approach for Combating SARS-CoV-2 |
Supriya Roy, Suneela Dhaneshwar |
| 36 |
[GO] |
2020―Sep―02 |
Is it possible to control the outbreak of COVID-19 in Dharavi, Asia's largest slum situated in Mumbai? |
Ranjan K. Mohapatra, Mizanur Rahman |
